Long-Term Safety of Growth Hormone Deficiency Treatment in Cancer and Sellar Tumors Adult Survivors: Is There a Role of GH Therapy on the Neoplastic Risk?

被引：4
作者：
Di Somma, Carolina [1 ,2 ]
Scarano, Elisabetta [1 ]
Arianna, Rossana [1 ]
Romano, Fiammetta [1 ]
Lavorgna, Mariarosaria [1 ]
Serpico, Domenico [1 ]
Colao, Annamaria [1 ,2 ]
机构：
[1] Univ Naples Federico II, Dept Clin Med & Surg, Endocrinol Diabet & Androl Unit, I-80131 Naples, Italy
[2] Univ Naples Federico II, UNESCO Chair Educ Hlth & Sustainable Dev, I-80131 Naples, Italy
来源：
JOURNAL OF CLINICAL MEDICINE | 2023年 / 12卷 / 02期
关键词：
GH treatment; cancer risk; GHD; NONFUNCTIONING PITUITARY-ADENOMA; CHILDHOOD-CANCER; REPLACEMENT THERAPY; FACTOR-I; HYPOPITUITARY PATIENTS; SUBSEQUENT NEOPLASMS; 2ND NEOPLASMS; BRAIN-TUMORS; RADIATION-THERAPY; ENDOCRINE-SOCIETY;
D O I：
10.3390/jcm12020662
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Experimental studies support the hypothesis that GH/IGF-1 status may influence neoplastic tissue growth. Epidemiological studies suggest a link between GH/IGF-1 status and cancer risk. However, several studies regarding GH replacement safety in childhood cancer survivors do not show a prevalence excess of de novo cancers, and several reports on children and adults treated with GH have not shown an increase in observed cancer risk in these patients. The aim of this review is to provide an at-a-glance overview and the state of the art of long-term effects of GH replacement on neoplastic risk in adults with growth hormone deficiency who have survived cancer and sellar tumors.
引用
收藏
页数：15
相关论文
共 110 条
[41]   Hypopituitarism [J].
Higham, Claire E. ;
Johannsson, Gudmundur ;
Shalet, Stephen M. .
LANCET, 2016, 388 (10058) :2403-2415
[42]   Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH research society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia [J].
Ho, Ken K. Y. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2007, 157 (06) :695-700
[43]   Three-year experience with access to nationally funded growth hormone (GH) replacement for GH-deficient adults [J].
Holdaway, I. M. ;
Hunt, P. ;
Manning, P. ;
Cutfield, W. ;
Gamble, G. ;
Ninow, N. ;
Staples-Moon, D. ;
Moodie, P. ;
Metcalfe, S. .
CLINICAL ENDOCRINOLOGY, 2015, 83 (01) :85-90
[44]   Safety of current recombinant human growth hormone treatments for adults with growth hormone deficiency and unmet needs [J].
Hoybye, Charlotte ;
Beck-Peccoz, Paolo ;
Simsek, Suat ;
Zabransky, Markus ;
Zouater, Hichem ;
Stalla, Guenter ;
Murray, Robert D. .
EXPERT OPINION ON DRUG SAFETY, 2020, 19 (12) :1539-1548
[45]   Molecular Pathways: Clinical Applications and Future Direction of Insulin-like Growth Factor-1 Receptor Pathway Blockade [J].
Iams, Wade T. ;
Lovly, Christine M. .
CLINICAL CANCER RESEARCH, 2015, 21 (19) :4270-4277
[46]   Does growth hormone cause cancer? [J].
Jenkins, PJ ;
Mukherjee, A ;
Shalet, SM .
CLINICAL ENDOCRINOLOGY, 2006, 64 (02) :115-121
[47]   Long-Term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients [J].
Johannsson, Gudmundur ;
Touraine, Philippe ;
Feldt-Rasmussen, Ulla ;
Pico, Antonio ;
Vila, Greisa ;
Mattsson, Anders F. ;
Carlsson, Martin ;
Korbonits, Marta ;
van Beek, Andre P. ;
Wajnrajch, Michael P. ;
Gomez, Roy ;
Yuen, Kevin C. J. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (07) :1906-1919
[48]   Risk Factors of Subsequent Central Nervous System Tumors after Childhood and Adolescent Cancers: Findings from the French Childhood Cancer Survivor Study [J].
Journy, Neige Marie Yvanne ;
Zrafi, Wael Salem ;
Bolle, Stephanie ;
Fresneau, Brice ;
Alapetite, Claire ;
Allodji, Rodrigue Setcheou ;
Berchery, Delphine ;
Haddy, Nadia ;
Kobayashi, Isao ;
Labbe, Martine ;
Pacquement, Helene ;
Pluchart, Claire ;
Schwartz, Boris ;
Souchard, Vincent ;
Thomas-Teinturier, Cecile ;
Veres, Cristina ;
Vu-Bezin, Giao ;
Diallo, Ibrahima ;
de Vathaire, Florent .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (01) :133-141
[49]   GROWTH-HORMONE DEFICIENCY FOLLOWING RADIATION-THERAPY OF PRIMARY BRAIN-TUMORS IN CHILDREN [J].
KANEV, PM ;
LEFEBVRE, JF ;
MAUSETH, RS ;
BERGER, MS .
JOURNAL OF NEUROSURGERY, 1991, 74 (05) :743-748
[50]   GH replacement does not increase the risk of recurrence in patients with craniopharyngioma [J].
Karavitaki, N ;
Warner, JT ;
Marland, A ;
Shine, B ;
Ryan, F ;
Arnold, J ;
Turner, HE ;
Wass, JAH .
CLINICAL ENDOCRINOLOGY, 2006, 64 (05) :556-560
12345678910